914 related articles for article (PubMed ID: 9700655)
1. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I
J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.
Iqbal K; Alonso AD; Gondal JA; Gong CX; Haque N; Khatoon S; Sengupta A; Wang JZ; Grundke-Iqbal I
J Neural Transm Suppl; 2000; 59():213-22. PubMed ID: 10961432
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention.
Iqbal K; Grundke-Iqbal I
J Cell Mol Med; 2008; 12(1):38-55. PubMed ID: 18194444
[TBL] [Abstract][Full Text] [Related]
4. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Wang JZ; Grundke-Iqbal I; Iqbal K
Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological targets to inhibit Alzheimer neurofibrillary degeneration.
Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Tsujio I; Grundke-Iqbal I
J Neural Transm Suppl; 2002; (62):309-19. PubMed ID: 12456074
[TBL] [Abstract][Full Text] [Related]
6. Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion.
Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Pei JJ; Tsujio I; Wang JZ; Grundke-Iqbal I
J Mol Neurosci; 2002; 19(1-2):95-9. PubMed ID: 12212801
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer neurofibrillary degeneration: therapeutic targets and high-throughput assays.
Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Pei JJ; Tanimukai H; Tsujio I; Wang JZ; Grundke-Iqba I
J Mol Neurosci; 2003; 20(3):425-9. PubMed ID: 14501027
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
Iqbal K; Grundke-Iqbal I
Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of neurofibrillary degeneration in Alzheimer's disease.
Iqbal K; Alonso AC; Gong CX; Khatoon S; Singh TJ; Grundke-Iqbal I
Mol Neurobiol; 1994; 9(1-3):119-23. PubMed ID: 7888088
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease.
Wang JZ; Grundke-Iqbal I; Iqbal K
Nat Med; 1996 Aug; 2(8):871-5. PubMed ID: 8705855
[TBL] [Abstract][Full Text] [Related]
11. Tau pathology in Alzheimer disease and other tauopathies.
Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of tau-induced neurodegeneration.
Iqbal K; Liu F; Gong CX; Alonso Adel C; Grundke-Iqbal I
Acta Neuropathol; 2009 Jul; 118(1):53-69. PubMed ID: 19184068
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological approaches of neurofibrillary degeneration.
Iqbal K; Grundke-Iqbal I
Curr Alzheimer Res; 2005 Jul; 2(3):335-41. PubMed ID: 15974899
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathology of Alzheimer neurofibrillary degeneration.
Iqbal K; Alonso A; Gong C; Khatoon S; Kudo T; Singh T; Grundke-Iqbal I
Acta Neurobiol Exp (Wars); 1993; 53(1):325-35. PubMed ID: 8317268
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of Alzheimer's neurofibrillary degeneration and therapeutic intervention.
Iqbal K; Grundke-Iqbal I
Ann N Y Acad Sci; 1996 Jan; 777():132-8. PubMed ID: 8624075
[TBL] [Abstract][Full Text] [Related]
16. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.
Wang JZ; Xia YY; Grundke-Iqbal I; Iqbal K
J Alzheimers Dis; 2013; 33 Suppl 1():S123-39. PubMed ID: 22710920
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of neurofibrillary degeneration: a promising approach to Alzheimer's disease and other tauopathies.
Iqbal K; Grundke-Iqbal I
Curr Drug Targets; 2004 Aug; 5(6):495-502. PubMed ID: 15270196
[TBL] [Abstract][Full Text] [Related]
18. Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity.
Alonso Adel C; Li B; Grundke-Iqbal I; Iqbal K
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8864-9. PubMed ID: 16735465
[TBL] [Abstract][Full Text] [Related]
19. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B.
Wang JZ; Gong CX; Zaidi T; Grundke-Iqbal I; Iqbal K
J Biol Chem; 1995 Mar; 270(9):4854-60. PubMed ID: 7876258
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer paired helical filaments. Restoration of the biological activity by dephosphorylation.
Iqbal K; Zaidi T; Bancher C; Grundke-Iqbal I
FEBS Lett; 1994 Jul; 349(1):104-8. PubMed ID: 8045285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
